INmune Bio Inc. (INMB) PT Raised to $23 at Scotiabank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
INmune Bio Inc. (INMB) PT Raised to $23 at Raymond James
February 12, 2025 5:12 AM ESTRaymond James analyst Gary Nachman raised the price target on INmune Bio Inc. (NASDAQ: INMB) to $23.00 (from $18.00) while maintaining a Outperform rating.
The analyst comments "INMB announced a positive clinical/regulatory update and hosted an informative webcast for CORDStrom (MSC platform) for Recessive... More
